Manulife (Manufacturers Life Insurance)
GBT

Manulife (Manufacturers Life Insurance)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,276
Closed -$1.65M – 3046
2022
Q3 		$1.65M Sell
24,276
-18,110
-43% -$999K ﹤0.01% 1431
2022
Q2 		$1.36M Buy
42,386
+3,268
+8% +$95.7K ﹤0.01% 1519
2022
Q1 		$1.36M Buy
39,118
+7,798
+25% +$233K ﹤0.01% 1620
2021
Q4 		$922 Sell
31,320
-283
-0.9% -$8.77K ﹤0.01% 1888
2021
Q3 		$805K Sell
31,603
-2,302
-7% -$67.7K ﹤0.01% 1977
2021
Q2 		$1.19M Buy
+33,905
New +$1.32M ﹤0.01% 1889
2020
Q2 		– Sell
-36,651
Closed -$1.87M – 2968
2020
Q1 		$1.87M Buy
36,651
+2,017
+6% +$135K ﹤0.01% 1320
2019
Q4 		$2.75M Sell
34,634
-657
-2% -$38.9K ﹤0.01% 1330
2019
Q3 		$1.74M Buy
35,291
+1,774
+5% +$92.5K ﹤0.01% 1411
2019
Q2 		$1.76M Sell
33,517
-1,118
-3% -$64.2K ﹤0.01% 1417
2019
Q1 		$1.83M Buy
34,635
+3,861
+13% +$190K ﹤0.01% 1444
2018
Q4 		$1.26M Sell
30,774
-1,576
-5% -$59.1K ﹤0.01% 1502
2018
Q3 		$1.23M Sell
32,350
-4,603
-12% -$204K ﹤0.01% 1677
2018
Q2 		$1.67M Buy
36,953
+7,896
+27% +$360K ﹤0.01% 1568
2018
Q1 		$1.4M Buy
29,057
+550
+2% +$30.7K ﹤0.01% 1649
2017
Q4 		$1.12M Buy
28,507
+127
+0.4% +$4.74K ﹤0.01% 1781
2017
Q3 		$881K Sell
28,380
-598
-2% -$16.8K ﹤0.01% 1878
2017
Q2 		$792K Buy
28,978
+14,509
+100% +$432K ﹤0.01% 1948
2017
Q1 		$533K Buy
14,469
+1,451
+11% +$36.5K ﹤0.01% 2134
2016
Q4 		$188K Buy
13,018
+1,047
+9% +$18.4K ﹤0.01% 2835
2016
Q3 		$276K Buy
11,971
+1,485
+14% +$28.3K ﹤0.01% 2533
2016
Q2 		$174K Buy
10,486
+5,390
+106% +$109K ﹤0.01% 2818
2016
Q1 		$76K Buy
5,096
+3,904
+328% +$69.4K ﹤0.01% 3161
2015
Q4 		$39 Buy
+1,192
New +$51.6K ﹤0.01% 3312

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GBT Position: Q4 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 24,276 shares — an estimated $1.65M sold.

Manulife (Manufacturers Life Insurance) first reported a position in GBT in Q4 2015 and held it in 24 quarters. The position peaked at $2.75M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 24,276 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.65M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 24 quarters.
  • Manulife (Manufacturers Life Insurance)'s Global Blood Therapeutics, Inc. position peaked at $2.75M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.